RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Johnson & Johnson P/S 2024

Johnson & Johnson P/S

4.19

Johnson & Johnson Dividend yield

3.22 %

Ticker

JNJ

ISIN

US4781601046

WKN

853260

As of Apr 28, 2024, Johnson & Johnson's P/S ratio stood at 4.19, a -9.89% change from the 4.65 P/S ratio recorded in the previous year.

The Johnson & Johnson P/S history

Johnson & Johnson Aktienanalyse

What does Johnson & Johnson do?

Johnson & Johnson is an American company that was founded in 1886 by the brothers Robert, James, and Edward Johnson. The company is headquartered in New Brunswick, New Jersey, USA and is now an internationally operating company with more than 130,000 employees worldwide. The history of Johnson & Johnson began with the production of medical bandages. In 1887, the first self-adhesive wound plaster was invented and patented. In the following years, the product range was significantly expanded and now includes a wide range of health products. This includes pharmaceuticals, medical devices, hygiene products, personal care products, and baby products. The business model of Johnson & Johnson is to improve the lives of people worldwide. The company places great importance on innovation, quality, and sustainability. With its long-standing experience and expertise in the healthcare industry, Johnson & Johnson is able to understand the needs of customers and offer products tailored to their specific needs. Johnson & Johnson is now active in three main business areas: Consumer Health, Medical Devices and Diagnostics, and Pharmaceuticals. Within these business areas, there are a variety of brands and products that are among the most well-known in the world. The Consumer Health division of Johnson & Johnson is focused on the production of health and personal care products for consumers. Some well-known brands in this area include Listerine, Johnson's Baby, Neutrogena, and Nicorette. The company offers a wide range of products, from cold and allergy medications to skincare products and toothpastes. Medical Devices and Diagnostics is another major business area of Johnson & Johnson. The company is a leading provider of medical devices and diagnostic products worldwide. Products in this area include surgical systems, implantable devices, diagnostic tests, and imaging devices. Well-known brands in this area include Ethicon, Depuy Synthes, and Cordis. Pharmaceuticals is the third major business area of Johnson & Johnson. The company develops and produces innovative pharmaceuticals for the treatment of diseases such as cancer, diabetes, heart disease, and neurological disorders. Some well-known brands in this area include Remicade, Invega, and Zytiga. Johnson & Johnson is also known for its commitment to sustainability and corporate social responsibility. The company is committed to having a positive impact on the environment and the communities in which it operates. For example, Johnson & Johnson aims to reduce its CO2 emissions by 60% by 2030. Overall, Johnson & Johnson is a leading healthcare company focused on providing innovative and high-quality products that improve the lives of people worldwide. With a wide range of brands and products in various business areas, the company is well positioned to continue to be successful in the future. Johnson & Johnson ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Johnson & Johnson's P/S Ratio

Johnson & Johnson's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Johnson & Johnson's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Johnson & Johnson's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Johnson & Johnson’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Johnson & Johnson Stock

What is the price-to-earnings ratio of Johnson & Johnson?

The price-earnings ratio of Johnson & Johnson is currently 4.19.

How has the price-earnings ratio of Johnson & Johnson changed compared to last year?

The price-to-earnings ratio of Johnson & Johnson has increased by -9.89% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Johnson & Johnson high compared to other companies?

Yes, the price-to-earnings ratio of Johnson & Johnson is high compared to other companies.

How does an increase in the price-earnings ratio of Johnson & Johnson affect the company?

An increase in the price-earnings ratio of Johnson & Johnson would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Johnson & Johnson affect the company?

A decrease in the price-earnings ratio of Johnson & Johnson would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Johnson & Johnson?

Some factors that influence the price-earnings ratio of Johnson & Johnson are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Johnson & Johnson pay?

Over the past 12 months, Johnson & Johnson paid a dividend of 4.7 USD . This corresponds to a dividend yield of about 3.22 %. For the coming 12 months, Johnson & Johnson is expected to pay a dividend of 5.1 USD.

What is the dividend yield of Johnson & Johnson?

The current dividend yield of Johnson & Johnson is 3.22 %.

When does Johnson & Johnson pay dividends?

Johnson & Johnson pays a quarterly dividend. This is distributed in the months of September, December, March, June.

How secure is the dividend of Johnson & Johnson?

Johnson & Johnson paid dividends every year for the past 63 years.

What is the dividend of Johnson & Johnson?

For the upcoming 12 months, dividends amounting to 5.1 USD are expected. This corresponds to a dividend yield of 3.49 %.

In which sector is Johnson & Johnson located?

Johnson & Johnson is assigned to the 'Health' sector.

Wann musste ich die Aktien von Johnson & Johnson kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Johnson & Johnson from 6/4/2024 amounting to 1.24 USD, you needed to have the stock in your portfolio before the ex-date on 5/20/2024.

When did Johnson & Johnson pay the last dividend?

The last dividend was paid out on 6/4/2024.

What was the dividend of Johnson & Johnson in the year 2023?

In the year 2023, Johnson & Johnson distributed 4.45 USD as dividends.

In which currency does Johnson & Johnson pay out the dividend?

The dividends of Johnson & Johnson are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Johnson & Johnson stock can be added to a savings plan with the following providers: Trade Republic, ING, Scalable Capital and Consorsbank

Andere Kennzahlen von Johnson & Johnson

Our stock analysis for Johnson & Johnson Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Johnson & Johnson Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.